Silverback Therapeutics: Funding, Investors & Team (Oct 2026)
Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways. They developing a new generation of systemically delivered, locally active therapies that potently modulate fundamental disease pathways once deemed inaccessible. Silverback Therapeutics is building a platform technology capable of unlocking potent immuno-modulatory pathways using an established antibody-guided approach for targeting disease sites. The company's proprietary ImmunoTAC technology and integrated R&D approach enables the design of product candidates that can be administered systemically, but that act only at the sites of disease.
Silverback Therapeutics has raised $85.0M across 1 funding round on record, the most recent an undisclosed round of $85.0M announced in Sep 2020.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Silverback Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Silverback Therapeutics Funding Rounds
Silverback Therapeutics Founders and Leadership Team
Contact details for the Silverback Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Silverback Therapeutics Funding Compared to Other Biotechnology Startups
Silverback Therapeutics' latest round of $85.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Silverback Therapeutics in Biotechnology and Seattle
Companies Similar to Silverback Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Silverback Therapeutics Funding FAQs
What does Silverback Therapeutics do?
Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways. They developing a new generation of systemically delivered, locally active therapies that potently modulate fundamental disease pathways once deemed inaccessible. Silverback Therapeutics is building a platform technology capable of unlocking potent immuno-modulatory pathways using an established antibody-guided approach for targeting disease sites. The company's proprietary ImmunoTAC technology and integrated R&D approach enables the design of product candidates that can be administered systemically, but that act only at the sites of disease.
How much funding has Silverback Therapeutics raised?
Silverback Therapeutics has raised $85.0M across 1 round on record. The most recent is an undisclosed round of $85.0M announced in Sep 2020.
When did Silverback Therapeutics last raise funding?
Silverback Therapeutics' most recent funding round on record is an undisclosed round of $85.0M, announced in Sep 2020.
Who is the CEO of Silverback Therapeutics?
Peter Thompson is listed as CEO at Silverback Therapeutics.
Where is Silverback Therapeutics headquartered?
Silverback Therapeutics is based in Seattle, Washington, United States.
How many employees does Silverback Therapeutics have?
Silverback Therapeutics is in the 51-100 employee band.
How does Silverback Therapeutics' funding compare to other Biotechnology startups?
Silverback Therapeutics' latest round of $85.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Silverback Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Silverback Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.